Bases on the serum butyrylcholinesterase levels (14) or brain derived neurotrophic factor (15), we may identify type 2 diabetes based on the cholinesterase levels, and may identify diabetes associated alzheimer’s disease (16). This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.